Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.

MLA

Inoue, Kazuyuki, et al. “Influence of Glutamine Synthetase Gene Polymorphisms on the Development of Hyperammonemia during Valproic Acid-Based Therapy.” Seizure, vol. 33, Dec. 2015, pp. 76–80. EBSCOhost, https://doi.org/10.1016/j.seizure.2015.10.015.

APA

Inoue, K., Takahashi, T., Yamamoto, Y., Suzuki, E., Takahashi, Y., Imai, K., Inoue, Y., Hirai, K., Tsuji, D., & Itoh, K. (2015). Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy. Seizure, 33, 76–80. https://doi.org/10.1016/j.seizure.2015.10.015

Chicago

Inoue, Kazuyuki, Toshiki Takahashi, Yoshiaki Yamamoto, Eri Suzuki, Yukitoshi Takahashi, Katsumi Imai, Yushi Inoue, Keita Hirai, Daiki Tsuji, and Kunihiko Itoh. 2015. “Influence of Glutamine Synthetase Gene Polymorphisms on the Development of Hyperammonemia during Valproic Acid-Based Therapy.” Seizure 33 (December): 76–80. doi:10.1016/j.seizure.2015.10.015.